Form 8-K - Current report:
SEC Accession No. 0001193125-19-029550
Filing Date
2019-02-06
Accepted
2019-02-06 16:12:30
Documents
2
Period of Report
2019-02-04
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d692256d8k.htm 8-K 23709
2 EX-3.1 d692256dex31.htm EX-3.1 161155
  Complete submission text file 0001193125-19-029550.txt   186249
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24006 | Film No.: 19571695
SIC: 2834 Pharmaceutical Preparations